The best protection from COVID-19 will come from intranasally-delivered vaccines, due to the effectiveness of mucosal IgA antibodies, say researchers from the University at Buffalo.
List view / Grid view
University at Buffalo
In an exclusive with Drug Target Review, researchers at the University at Buffalo explain how they developed a novel peptide that could be a future treatment for chronic inflammatory pain.
Researchers have published a step-by-step protocol on how to produce millions of mature human cells in a chimeric mouse embryo.